{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:30:08Z","timestamp":1772555408435,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.urolonc.2018.09.010","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T20:10:31Z","timestamp":1539634231000},"page":"532.e1-532.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Semen AMACR protein as a novel method for detecting prostate cancer"],"prefix":"10.1016","volume":"36","author":[{"given":"Tyler","family":"Etheridge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Straus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Jarrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2018.09.010_bib0001","first-page":"71","article-title":"Cancer statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0002","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/00005392-199805000-00050","article-title":"Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate","volume":"159","author":"Jung","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0003","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000092583","article-title":"Should men with serum prostate-specific antigen < or =4 ng\/ml and normal digital rectal examination undergo a prostate biopsy? A literature review","volume":"70","author":"Pepe","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0004","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1097\/01.ju.0000119667.86071.e7","article-title":"Predictors of prostate cancer after initial negative systematic 12 core biopsy","volume":"171","author":"Singh","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0005","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0090-4295(02)01958-1","article-title":"Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program","volume":"60","author":"Raaijmakers","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0006","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0090-4295(00)00863-3","article-title":"Prostate-specific antigen-based early detection of prostate cancer\u2013validation of screening without rectal examination","volume":"57","author":"Schr\u00f6der","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0007","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1001\/jama.287.13.1662","article-title":"alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer","volume":"287","author":"Rubin","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0008","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1158\/0008-5472.CAN-03-3881","article-title":"Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer","volume":"64","author":"Rubin","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0009","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0046-8177(03)00268-5","article-title":"Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases","volume":"34","author":"Jiang","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/01.pap.0000146924.14246.be","article-title":"Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy","volume":"11","author":"Jiang","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0011","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0012","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00000478-200306000-00007","article-title":"Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer","volume":"27","author":"Zhou","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0013","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.pas.0000149710.01559.fe","article-title":"Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver","volume":"29","author":"Hornick","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0014","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00000478-200401000-00007","article-title":"Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma","volume":"28","author":"Tretiakova","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0015","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/1055-9965.EPI-04-0607","article-title":"Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis","volume":"14","author":"Witkiewicz","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0016","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/01.pas.0000131544.18266.a4","article-title":"Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma","volume":"28","author":"Gupta","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0017","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.pas.0000213268.30468.b4","article-title":"AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease","volume":"30","author":"Dorer","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0018","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/01.ju.0000137659.53129.14","article-title":"Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein","volume":"172","author":"Rogers","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0019","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.ju.0000133560.87118.4d","article-title":"A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions","volume":"172","author":"Zielie","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0020","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/jnci\/djh145","article-title":"Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer","volume":"96","author":"Sreekumar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0021","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.urology.2009.11.056","article-title":"Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes","volume":"76","author":"Carvalhal","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0022","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.urology.2007.12.009","article-title":"Time-to-ejaculation and the quality of semen produced by masturbation at a clinic","volume":"71","author":"Elzanaty","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0023","first-page":"1101","article-title":"Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters","volume":"8","author":"Oberst","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0024","first-page":"1101","article-title":"Tissue microarray analysis of hepatocyte growth factor\/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer","volume":"63","author":"Kang","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0025","doi-asserted-by":"crossref","first-page":"C40","DOI":"10.1152\/ajpcell.00351.2005","article-title":"Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells","volume":"291","author":"Kiyomiya","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0026","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1055-9965.EPI-05-0737","article-title":"A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1","volume":"15","author":"Saleem","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/PAI.0b013e31817c3334","article-title":"Protein expression of matriptase and its cognate inhibitor HAI-1 in human prostate cancer: a tissue microarray and automated quantitative analysis","volume":"17","author":"Warren","year":"2009","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0028","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/01.ju.0000142448.58831.d9","article-title":"Using molecular markers to predict outcome","volume":"172","author":"Rubin","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0029","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/bj20030390","article-title":"Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues","volume":"373","author":"Hooper","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0030","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L","article-title":"Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer","volume":"71","author":"Stamey","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0031","first-page":"421","article-title":"Beta-human chorionic gonadotropin in semen: a marker for early detection of prostate cancer?","volume":"4","author":"Daja","year":"2000","journal-title":"Mol Urol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0032","first-page":"5941","article-title":"Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids","volume":"60","author":"Goessl","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0033","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/1078-0432.CCR-06-2679","article-title":"The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance","volume":"13","author":"van Gils","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0034","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.eururo.2004.06.004","article-title":"DD3PCA3 RNA analysis in urine\u2014a new perspective for detecting prostate cancer","volume":"46","author":"Tinzl","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0035","doi-asserted-by":"crossref","DOI":"10.5301\/jbm.5000146","article-title":"Alpha-methylacyl-CoA racemase and hepsin as urinary prostate cancer markers","volume":"30","author":"Sroka","year":"2015","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0036","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2559.2004.01930.x","article-title":"Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker","volume":"45","author":"Jiang","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0037","first-page":"2220","article-title":"Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer","volume":"62","author":"Luo","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0038","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/00000478-200212000-00006","article-title":"P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies","volume":"26","author":"Beach","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0039","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2559.2007.02572.x","article-title":"Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score","volume":"50","author":"Murphy","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0040","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/01.pas.0000180855.66948.5e","article-title":"Age-associated changes in alpha-methyl CoA racemase (AMACR) expression in nonneoplastic prostatic tissues","volume":"29","author":"Gologan","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0041","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/jrf.0.0370179","article-title":"Secretory function of the prostate, seminal vesicle and other male accessory organs of reproduction","volume":"37","author":"Mann","year":"1974","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0042","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0022-5320(70)90179-6","article-title":"On the mechanism of lysosomal enzyme secretion. Electron microscopic and histochemical studies on the epithelial cells of the rat's ventral prostate lobe","volume":"33","author":"Helminen","year":"1970","journal-title":"J Ultrastruct Res"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0043","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1440-1827.2003.01499.x","article-title":"Distribution and secretory pathways of prostate specific antigen, alpha1-antichymotrypsin and prostate secretory granules in prostate cancers","volume":"53","author":"Ishida","year":"2003","journal-title":"Pathol Int"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0044","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0046-8177(98)90020-X","article-title":"Characterization of cytoplasmic secretory granules (PSG), in prostatic epithelium and their transformation-induced loss in dysplasia and adenocarcinoma","volume":"29","author":"Cohen","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0046-8177(00)80204-X","article-title":"Luminal contents of benign and malignant prostatic glands: correspondence to altered secretory mechanisms","volume":"31","author":"Cohen","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2018.09.010_bib0046","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814391830351X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814391830351X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:15:25Z","timestamp":1761041725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814391830351X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S107814391830351X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.09.010","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semen AMACR protein as a novel method for detecting prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}